YUCAIPA, Calif., Aug. 30, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a medical device manufacturer with an emerging new medical product line targeting the $8 billion respiratory market, announced today that it has received a letter of confirmation from the Armed Services Association in Washington, D.C. stating that the company is now registered with the U.S. Central Contractor Registry (CCR), which qualifies it to do business with the U.S. Department of Defense (DoD).
The United States Military Purchasing Directory is distributed to all purchasing offices throughout the DoD every fiscal year. Purchasing officers and DoD contracting personnel specifically use the directory to locate vendors from whom they will buy goods and services. This directory now includes Ingen Technologies, Inc.
After visiting 60 military facilities and introducing Ingen's new respiratory product line that includes 2 models of the Oxyview flow meter and 6 new models of the Smart Nasal Cannulas, KGMA Business Solutions previously projected that approximately 60 military facilities had an interest in allocating unspent funds to purchase $1.4 million worth of the respiratory products by the end of this year.
"After successfully registering with the CCR, Ingen is now rapidly expanding its sales in the U.S. military marketplace," said Ingen Chairman and CEO, Scott R. Sand. "We look forward to our upcoming conference on September 8, 2010 in Frederick, Maryland, as we continue our expansion efforts."
Investors can review our current fact sheet at the following link:
Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010, the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements:
This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
CONTACT: Ingen Technologies Jeff Morgan 909-790-7180 email@example.com www.ingen-tech.com